Gold stock Harmony Gold Mining and auto parts maker Adient are highlighted out of 10 names that made today's IBD Screen Of The Day. The Global Leaders screen identifies leading stocks that are based outside the U.S.
South African-based Harmony Gold is dancing around a buy point as gold prices touch $4,000 an ounce. And Ireland-based Adient is also taunting investors as it trades around an entry point and its 52-week high.
Gold Stock Teases Near A Buy Point
On Monday, IBD 50 stock Harmony Gold Mining hit an 18.77 buy point from an early-stage cup base, but the stock faded below the entry by the session's end. Shares were down Tuesday amid the market drop. This was its third attempt at breaking out of the 23-week long base out of the last four sessions.
The gold stock is also trading around its all-time high of 18.94, reached on Oct. 2.
Harmony Gold Mining is the largest gold producer by volume in South Africa. Harmony operates gold mines in South Africa and Papua New Guinea. As part of its long-term growth strategy, it's expanding its copper mining footprint, with projects in Papua New Guinea and Australia.
The gold stock is tied for the No. 1 spot out of 79 stocks in Investor's Business Daily's Mining-Gold/Silver/Gems group, which holds the 4th spot out of the 197 industry groups that IBD tracks.
The gold stock is on pace for six straight weeks of gains and has climbed around 126% so far this year. And its 1.4 up/down volume ratio shows positive demand for Harmony stock over the last 50 days.
The gold producer's profit doubled in fiscal 2026 to $2.62 per share while its revenue grew 20%.
Analysts' forecasts call for fiscal 2027 earnings to rise nearly 13% to $2.95 per share.
It has a 96 IBD Earnings Per Share Rating and a three-year EPS growth rate of 75%, according to IBD Stock Checkup.
Finally, Harmony Gold stock holds a best-possible 99 Composite Rating.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
Auto Parts Stock Dances Around An Entry
On Friday, Adient stock reached the 25.84 buy point of a stage-one flat base, according to MarketSurge chart analysis. But shares wavered for a second straight day and closed just below the entry Monday. Shares were falling amid a market sell-off Tuesday.
Its IBD Accumulation/Distribution Rating of A- indicates fairly heavy institutional buying over the last 13 weeks, helping push up its share price.
The stock has had a relentlessness climb from a low of 10.04 in April to its current price around 25.78. The stock has ridden its 10-week moving average up since early May, before testing and bouncing off it last week.
Adient topped fiscal third-quarter earnings and sales estimates on Aug. 6. Its bottom line has greatly improved, with its profit rising 41% vs. a 13% drop two quarters ago.
Lackluster Sales
Meanwhile, its sales have been lackluster. Adient's fiscal third-quarter revenue inched up 1% after six straight declining quarters. Management raised its fiscal 2025 revenue outlook to $14.4 billion, but that lags its $14.688 billion sales in fiscal 2024.
Adient will host a conference call on Nov. 5, to discuss its fiscal fourth-quarter results. Wall Street projections see its profit growing a modest 2% in fiscal 2025 then jumping 25% in fiscal 2026.
Adient designs and makes complete auto seats including hardware, foam and trim. It has more than 200 manufacturing and assembly plants worldwide.
It ranks No. 3 out of 39 stocks in Investor's Business Daily's Auto/Truck Original Equipment group, which ranks No. 18 out of the 197 IBD industry groups.
Follow Kimberley Koenig for more stock market news on X, the platform formerly known as Twitter, @IBD_KKoenig.
